References
- Tsai HM. Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura. J Am Soc Nephrol 2003;14:1072–1081.
- Tsai HM, Lian ECY. Antibodies to von-Willebrand factor cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998;339:1585–1594.
- von Baeyer H. Plasmapheresis in thrombotic microangiopathy-associated syndromes: Review of outcome data derived from clinical trials and open studies. Ther Apher 2002;6:320–328.
- Kaplan AA. A simple and accurate method for prescribing plasma exchange. Trans Am Soc Artif Intern Organs 1990;36: 597–599.
- Rock GA, Shumak KH, Buskard NA, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 1991; 325:393–397.
- Rock G, Shumak K, Kelton J, et al. Thrombotic thrombo-cytopenic purpura: Outcome in 24 patients with renal impairment treated with plasma exchange. Transfusion 1992; 32:710–714.
- Bell WR, Braine HG, Ness PM. Improved survival in thrombotic thrombocytopenic purpura-hemolytic-uremic syn-drome. Clinical experience in 108 patients. N Engl J Med 1991;325: 398–403.
- George JN. How I treat patients with thrombotic thrombo-cytopenic purpura-hemolytic uremic syndrome. Blood 2000; 96:1223–1229.
- Hayward CPM, Sutton DMC, Carter WH, Jr, et al. Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Arch Intern Med 1994; 154:982–987.
- Shumak KH, Rock GA, Nair RC. The Canadian Apheresis Group. Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura. Ann Intern Med 1995;122:572–596.
- Vesely SK, George JN, Raskob GE. Longterm clinical outcomes of thrombotic thrombocytopenic purpura—hemo-ytic-uremic syndrome (TTP—HUS) among different patients groups. Blood 1999;94:15a.
- Remuzzi G, Ruggenenti P. The hemolytic uremic syndrome. Kidney Int 1995;47:2–19.
- Ruggegenti P, Remuzzi G. The patophysiology and manage-ment of thrombotic thrombocytopenic purpura. Eur J Haematol 1996;56:191–207.
- Kincaid-Smith P. Participation of intravascular coagulation in the pathogenesis of glomerular and vascular lesions. Kidney Int 1975;7:242–253.
- Hollenbeck M, Kutkuhn B, Aul C, Lecshke M, Willers R, Grabensee B. Haemolytic-uremic syndrome and thrombotic-thrombocytopenic purpura in adults: Clinical findings and prognostic factors for death and end-stage renal disease. Nephrol Dial Transplant 1998;13:76–81.
- Kes P. Efficacy of therapeutic plasma exchange in specific renal disease. Acta Med Croatica 1998;52:49–63.
- Basic-Jukic N, Kes P, Puretic Z, et al. Complications of plasma exchange. Experience with 4857 treatments. Ther Apher Dial 2005;9: 391–395.
- Rizvi MA, Vesely SK, George JN, et al. Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic-uremic syndrome. Transfusion 2000;40:896–901.
- Bueno D, Jr, Sevigny J, Kaplan AA. Extracorporeal treatment of thrombotic microangiopathy: A ten year experience. Ther Apher 1999;3:294–297.
- Kelton JG. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: Will recent insight into patho-genesis transplate into better treatment? Transfusion 2002;42: 388–392.